scholarly journals Chk2-p53 and JNK in irradiation-induced cell death of hematopoietic progenitors and differentiated cells in Drosophila larval lymph gland

Biology Open ◽  
2021 ◽  
Author(s):  
Tram Thi Ngoc Nguyen ◽  
Jiwon Shim ◽  
Young-Han Song

Ionizing radiation (IR) induces DNA double-strand breaks that activate the DNA damage response (DDR), which leads to cell cycle arrest, senescence, or apoptotic cell death. Understanding the DDR of stem cells is critical to tissue homeostasis and the survival of the organism. Drosophila hematopoiesis serves as a model system for sensing stress and environmental changes; however, their response to DNA damage remains largely unexplored. The Drosophila lymph gland is the larval hematopoietic organ, where stem-like progenitors proliferate and differentiate into mature blood cells called hemocytes. We found that apoptotic cell death was induced in progenitors and hemocytes after 40 Gy irradiation, with progenitors showing more resistance to IR-induced cell death compared to hemocytes at a lower dose. Furthermore, we found that Drosophila ATM (tefu), Chk2 (lok), p53, and reaper were necessary for IR-induced cell death in the progenitors. Notably, IR-induced cell death in mature hemocytes required tefu, Drosophila JNK (bsk), and reaper, but not lok or p53. In summary, we found that DNA damage induces apoptotic cell death in the late third instar larval lymph gland and identified lok/p53-dependent and -independent cell death pathways in progenitors and mature hemocytes, respectively.

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Toshinori Ozaki ◽  
Akira Nakagawara ◽  
Hiroki Nagase

A proper DNA damage response (DDR), which monitors and maintains the genomic integrity, has been considered to be a critical barrier against genetic alterations to prevent tumor initiation and progression. The representative tumor suppressor p53 plays an important role in the regulation of DNA damage response. When cells receive DNA damage, p53 is quickly activated and induces cell cycle arrest and/or apoptotic cell death through transactivating its target genes implicated in the promotion of cell cycle arrest and/or apoptotic cell death such asp21WAF1,BAX, andPUMA. Accumulating evidence strongly suggests that DNA damage-mediated activation as well as induction of p53 is regulated by posttranslational modifications and also by protein-protein interaction. Loss of p53 activity confers growth advantage and ensures survival in cancer cells by inhibiting apoptotic response required for tumor suppression. RUNX family, which is composed of RUNX1, RUNX2, and RUNX3, is a sequence-specific transcription factor and is closely involved in a variety of cellular processes including development, differentiation, and/or tumorigenesis. In this review, we describe a background of p53 and a functional collaboration between p53 and RUNX family in response to DNA damage.


2014 ◽  
Vol 15 (2) ◽  
pp. 135-147 ◽  
Author(s):  
Tom Vanden Berghe ◽  
Andreas Linkermann ◽  
Sandrine Jouan-Lanhouet ◽  
Henning Walczak ◽  
Peter Vandenabeele

2014 ◽  
Vol 70 (4) ◽  
pp. 947-959 ◽  
Author(s):  
Svetlana Ivanović-Matić ◽  
Desanka Bogojević ◽  
Vesna Martinović ◽  
Anja Petrović ◽  
Sofija Jovanović-Stojanov ◽  
...  

2003 ◽  
Vol 84 (6) ◽  
pp. 1275-1287 ◽  
Author(s):  
Alejandro A. Romero ◽  
Stephane R. Gross ◽  
Ke-Yi Cheng ◽  
Noriko K. Goldsmith ◽  
Herbert M. Geller

2018 ◽  
Vol 27 (6) ◽  
pp. 890-901 ◽  
Author(s):  
Antonio Bruni ◽  
Stefan Bornstein ◽  
Andreas Linkermann ◽  
A. M. James Shapiro

Clinical islet transplantation effectively restores euglycemia and corrects glycosylated hemoglobin in labile type 1 diabetes mellitus (T1DM). Despite marked improvements in islet transplantation outcomes, acute islet cell death remains a substantial obstacle that compromises long-term engraftment outcomes. Multiple organ donors are routinely required to achieve insulin independence. Therapeutic agents that ameliorate cell death and/or control injury-related inflammatory cascades offer potential to improve islet transplant success. Apoptotic cell death has been identified as a major contributor to cellular demise and therapeutic strategies that subvert initiation and consequences of apoptotic cell death have shown promise in pre-clinical models. Indeed, in numerous pathologies and diseases apoptosis has been the most extensively described form of regulated cell death. However, recent identification of novel, alternative regulated cell death pathways in other disease states and solid organ transplantation suggest that these additional pathways may also have substantial relevance in islet transplantation. These regulated, non-apoptotic cell death pathways exhibit distinct biochemical characteristics but have yet to be fully characterized within islet transplantation. We review herein the various regulated cell death pathways and highlight their relative potential contributions to islet viability, engraftment failure and islet dysfunction.


APOPTOSIS ◽  
2009 ◽  
Vol 14 (11) ◽  
pp. 1289-1298 ◽  
Author(s):  
Zhiqun Zhang ◽  
Stephen F. Larner ◽  
Ming Cheng Liu ◽  
Wenrong Zheng ◽  
Ronald L. Hayes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document